Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema

PURPOSE: To evaluate the efficacy of intravitreal aflibercept injection (IAI) for vitrectomized eyes with diabetic macular edema (DME) at two years. METHODS: This is a prospective, non-comparative, multicenter observational study including diabetic patients with visual acuity between 20/400 to 20/40...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Thi Ha Chau, Verdun, Stephane, Le Rouic, Jean François, Uzzan, Joel, Milazzo, Solange, Kodjikian, Laurent, Erginay, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923833/
https://www.ncbi.nlm.nih.gov/pubmed/35310546
http://dx.doi.org/10.2147/OPTH.S352152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923833/
https://www.ncbi.nlm.nih.gov/pubmed/35310546
http://dx.doi.org/10.2147/OPTH.S352152

Ejemplares similares